Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis
Development of cardiac manifestations in patients diagnosed with inflammatory bowel disease undergoing treatment with mesalamine is a rare. When this occurs, it can be difficult to tease out the primary etiology, as both IBD and mesalamine can cause cardiac manifestations independently of each other...
Saved in:
Main Authors: | Kelechukwu U. Okoro, Matthew D. Roby, Adegbenga A. Bankole |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2018/9813893 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recurrent Inflammatory Myositis as an Extra-Intestinal Manifestation of Dormant Ulcerative Colitis in a Patient on Long-Term Mesalamine
by: Srikanth Naramala, et al.
Published: (2019-01-01) -
Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study
by: Sumaiah J. Alarfaj, et al.
Published: (2025-01-01) -
Amyloid Goiter Secondary to Ulcerative Colitis
by: Bunyamin Aydin, et al.
Published: (2016-01-01) -
Infiltrating Cardiac Synovial Sarcoma Presenting as Acute Cerebrovascular Accident
by: Kelechukwu U. Okoro, et al.
Published: (2017-01-01) -
Results of formation of primary and secondary smallintestinal reservoirs at ulcerative colitis
by: V. N. Kashnikov, et al.
Published: (2014-12-01)